Goal 3: Good Health and Well-Being
 |
McMaster researcher Gerry Wright is a trailblazer in antimicrobial discovery, leading the global fight against superbugs and antibiotic resistance. He leads a global network that is working to prevent future pandemics as part of SDG 3. |
Preventing A SLOW-MOVING CATASTROPHE
Antibiotics are essential to modern medicine. We rely on them to cure everything from pneumonia to meningitis. The infection control they provide makes life-saving treatments like cancer chemotherapy and heart transplants possible.
But widespread overuse of these drugs in agriculture and medicine have led bacteria to evolve, increasing resistance to penicillin and related medicines. Antibiotic resistance causes 700,000 deaths globally each year – a number that’s expected to rise to 10 million by 2050.
The stakes couldn’t be higher.
That’s why infectious disease expert Gerry Wright is working with teams of researchers to understand and detect antimicrobial resistance, and develop new treatments to stop this global threat in its tracks.
Featured Stories
Exploring the Arctic
Despite documented health disparities between the circumpolar north and other regions, work in the Arctic makes up a small proportion of global health research overall. . . .
$4M launches national study on COVID-19 antibodies in older adults
A $4-million investment from Canada’s COVID-19 Immunity Task Force will launch a national study to investigate the burden of SARS-CoV-2 infection among aging Canadians, a . . .
McMaster opens Centre of Excellence to advance personal protective equipment in Canada
McMaster University is now home to an established network of engineers, clinicians, local manufacturers and companies dedicated to advancing personal protective equipment products in Canada. . . .
Discover how Our Research is making an Impact
